$Palantir (PLTR.US)$ Shares of Palantir have dropped 30% sin...

Shares of Palantir have dropped 30% since the start of November, despite a fundamental business that continues to thrive.

In particular, Palantir has been successful at diversifying away from government contracts, with overall commercial revenue growth accelerating in Q3 and more than doubling in the U.S.

Still, the government business is not slacking, with the company winning recent contracts with the Air Force, Department of Health and Human Services, and National Institutes of Health.